Andrew Turitz joined Teladoc in 2015 as senior vice president of business development. He is responsible for identifying, evaluating and executing growth opportunities for Teladoc through partnerships, acquisitions, joint ventures and other third-party transactions.
Drew has more than 12 years of experience in healthcare transactions, including the management of all phases of acquisitions, investments and partnerships—from analysis, diligence and transaction structuring to product integration, go-to-market strategies and operational integration.
Prior to joining Teladoc, Drew was a vice president of business development for Healthagen, a division of Aetna providing population health technology, accountable care and care management services to providers, payers, employers and consumers. He led acquisitions, investing and partnerships for Healthagen and its portfolio companies including iTriage, ActiveHealth, Medicity and Accountable Care Solutions.
From 2008 to 2012, Drew served as a vice president and then managing director for Sandbox Industries, which manages $300 million of capital for 20 Blue Cross/Blue Shield plans. At Sandbox, Drew led seed-to-growth-stage venture investments in Bloom Health, Change Healthcare, Zeomega and others. He served on the board of directors for numerous portfolio companies, and worked with them to form strategic and commercial relationships with Blue plans, develop new payer-focused business strategies, recruit executives and raise capital for follow-on investments.
Earlier, Drew was a vice president of healthcare investment banking for Bank of America. He specialized in healthcare mergers and acquisitions, providing strategic and financial advisory services to clients across all healthcare industry sectors.
Drew received a bachelor of arts degree from Stanford University and a master of business administration degree from the Kellogg School of Management at Northwestern University.